分子品管市場－全球產業規模、佔有率、趨勢、機會及預測（依產品、分析物類型、應用、最終用戶、地區及競爭格局分類，2021-2031年）

全球分子品管市場預計將從 2025 年的 3.4 億美元成長到 2031 年的 5.1 億美元，複合年成長率為 6.99%。

分子品管是一項關鍵基準，檢驗使用合成或生物材料進行的核酸檢測的準確性，並確認臨床診斷的可靠性。這一成長主要得益於對實驗室認證標準（例如 ISO 15189）的嚴格遵守，這些標準要求定期進行能力驗證測試；此外，傳染病檢查和基因檢測的興起也需要檢驗的控制通訊協定。

儘管有這些正面因素，但由於第三方管理高成本以及與低溫運輸管理相關的物流挑戰，開發中地區的市場滲透仍面臨重大障礙。營運數據凸顯了該行業為應對日益複雜的檢測而做出的調整。例如，美國病理學家協會 (CAP) 於 2024 年推出了 18 項新的能力認證項目，以滿足臨床檢查室不斷變化的需求。

市場促進因素

分子診斷技術的進步，特別是次世代定序(NGS) 和多重檢測的廣泛應用，是推動先進品管解決方案需求的關鍵因素。隨著檢查室部署高通量系統來分析複雜的遺傳標記，對能夠檢驗廣泛基因組檢測並確保遺傳疾病篩檢和腫瘤學準確性的多分析物質控試劑的需求日益成長。 Illumina 公司在 2024 年 2 月發布的 2023 會計年度 10-K 報告中也強調了這項先進基因組基礎設施的擴展，報告指出 NovaSeq X 儀器的出貨量為 352 台，凸顯了需要嚴格品質保證的高複雜度檢測的激增。

同時，感染疾病的日益嚴峻促使人們迫切需要大規模分子檢測和嚴格檢驗診斷的準確性。全球對快速病原體檢測的日益重視，推動了臨床工作流程向分子技術轉型，而這需要持續的能力驗證測試，以確保符合監管要求並保障病人安全。例如，根據世界衛生組織（世衛組織）於2023年11月發布的《2023年全球結核病報告》，分子診斷的使用將達到頂峰，屆時47%的結核病初診將採用世衛組織建議的快速分子檢測方法。為了支持如此大規模的運營，Bio-Rad Laboratories報告稱，其2024年臨床診斷業務的淨銷售額約為15.3億美元，這充分體現了其在診斷信心和檢測支持方面的巨大價值。

市場挑戰

第三方分子品管產品的高昂採購成本是市場成長的主要障礙，尤其是在資源匱乏的環境中。新興經濟體的臨床檢查室往往面臨資金限制，難以證明購買昂貴的獨立品管以及其他營運需求的合理性。因此，這些機構可能會降低品管措施的頻率，或依賴標準較低的內部品管品，這不僅減少了商業生產商的商機，也損害了診斷結果的全球標準化。

此外，嚴格的低溫運輸物流要求也加重了這些經濟負擔。分子檢測品管通常需要在零度以下儲存以保持穩定性，而基礎設施不穩定的地區往往難以滿足此要求。這種物流上的脆弱性會導致產品劣化和廢棄物增加，進一步阻礙了分散式設施的部署。這些營運壓力的影響在近期的行業趨勢中顯而易見：根據診斷和實驗室醫學協會 (ADLM) 2024 年的一項調查，由於合規成本不斷上漲和資源限制，48% 的實驗室正在考慮停止某些檢測服務，從而縮小了分子品管產品的潛在市場。

市場趨勢

隨著獨立第三方品管材料的使用日益增多，市場格局正在發生重塑。為了滿足嚴格的認證要求，臨床檢查室優先考慮的是客觀的評估工具，而非試劑盒配件。這項轉變的驅動力在於降低批間差異，並確保不同試劑批次間診斷準確性的一致性，這對於符合 ISO 15189 標準至關重要。實驗室正積極採用這些獨立材料，以識別可能被製造商提供的品管最佳化基質相容性所掩蓋的系統性誤差。這項需求反映在 Bio-Rad Laboratories 於 2024 年 10 月發布的「2024 會計年度第三季財務業績」中，其臨床診斷部門報告淨銷售額達 3.888 億美元，主要得益於全球對品管產品的需求。

同時，為了簡化高通量檢測環境下的工作流程，業界正經歷著向多重、多分析物對照品的重大轉變。隨著診斷試劑生產商將多種標靶整合到單一的症候群檢測組合中，尤其是在消化器官系統和呼吸道病原體方面，檢查室需要能夠一次檢驗所有標靶的整合對照品，從而降低單分析物對照品相關的耗材成本和時間。這種整合增強了現代診斷中心的擴充性，Levity 於 2024 年 11 月發布的 2024 年第三季財務報告便印證了這一點。報告指出，診斷業務部門的收入達到 3.83 億美元（年增 6%），這主要得益於專業分子和免疫診斷解決方案的持續普及。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球分子品管市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 依產品分類（獨立控制、設備特定控制）
  • 依分析物類型（單分析物對照、多分析物對照）
  • 依應用領域（感染疾病診斷、腫瘤檢測、基因檢測等）
  • 按最終用戶分類（診斷檢查室、醫院、體外診斷試劑生產商和合約研究組織、學術研究機構等）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

6. 北美分子品管市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

7. 歐洲分子品管市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

8. 亞太地區分子品管市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

9. 中東和非洲分子品管市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章 南美洲分子品管市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進要素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 最新進展

第13章 全球分子品管市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的可能性
• 供應商電力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• F. Hoffmann-La Roche Ltd.
• Danaher Corporation
• Bio-Rad Laboratories, Inc.
• Anchor Molecular Inc.
• Thermo Fisher Scientific, Inc.
• Randox Laboratories Ltd.
• Abbott Laboratories Inc.
• Fortress Diagnostics Ltd
• Ortho-Clinical Diagnostics, Inc.
• Sun Diagnostics, LLC

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Molecular Quality Control Market is projected to expand from USD 0.34 Billion in 2025 to USD 0.51 Billion by 2031, registering a CAGR of 6.99%. Functioning as critical benchmarks, molecular quality controls employ synthetic or biological materials to validate nucleic acid testing precision and confirm the reliability of clinical diagnostics. This growth is primarily underpinned by strict adherence to laboratory accreditation norms, such as ISO 15189, which mandate regular proficiency testing, coupled with the increasing volume of infectious disease and genetic testing that necessitates verified control protocols.

Despite these positive indicators, market penetration in developing areas faces significant hurdles due to the high expense of third-party controls and the logistical difficulties associated with cold-chain management. Operational data highlights the industry's adaptation to increasing testing complexity; for instance, the College of American Pathologists launched 18 new proficiency testing programs in 2024 to meet the shifting requirements of clinical laboratories.

Market Driver

Advancements in molecular diagnostic technologies, specifically the widespread adoption of Next-Generation Sequencing and multiplex assays, are a major force behind the demand for sophisticated quality control solutions. As laboratories implement high-throughput systems to examine complex genetic markers, there is an intensified need for multi-analyte controls capable of validating extensive genomic panels, ensuring accuracy in hereditary disease screening and oncology. This expansion of advanced genomic infrastructure is evidenced by Illumina's 'Form 10-K Fiscal Year 2023' report from February 2024, which noted the shipment of 352 NovaSeq X instruments, highlighting the broader footprint of high-complexity testing that requires rigorous quality assurance.

Simultaneously, the increasing prevalence of infectious diseases serves as a catalyst, demanding high-volume molecular testing and strict verification of diagnostic precision. The global focus on rapid pathogen detection has reoriented clinical workflows toward molecular techniques, which require ongoing proficiency testing to ensure regulatory compliance and patient safety. For example, the World Health Organization's 'Global Tuberculosis Report 2023', released in November 2023, indicated that molecular diagnostics usage reached a peak, with 47% of initial tuberculosis diagnoses utilizing a WHO-recommended rapid molecular test. Supporting the scale of these operations, Bio-Rad Laboratories reported in 2024 that its Clinical Diagnostics segment achieved approximately $1.53 billion in annual net sales, demonstrating the significant value placed on diagnostic assurance and testing support.

Market Challenge

The substantial cost of acquiring third-party molecular quality controls represents a major obstacle to market growth, especially in resource-limited settings. Clinical laboratories in emerging economies often face financial constraints, making it difficult to justify the purchase of premium, independent control materials amidst other operational needs. As a result, these facilities might decrease the frequency of quality control measures or resort to less stringent in-house options, which reduces revenue opportunities for commercial manufacturers and compromises the global standardization of diagnostic outcomes.

Additionally, the strict logistical demands for maintaining cold-chain integrity during storage and transport intensify these financial burdens. Molecular controls typically require preservation at sub-zero temperatures to remain stable, a requirement often difficult to meet in areas with inconsistent infrastructure. This logistical vulnerability results in product spoilage and increased waste, further discouraging adoption in decentralized locations. The consequences of such operational pressures are highlighted by recent industry trends; according to a 2024 survey by the Association for Diagnostics & Laboratory Medicine, 48% of laboratories intended to stop specific testing services due to the growing weight of compliance costs and resource limitations, thereby shrinking the potential market for molecular quality control products.

Market Trends

The market is being reshaped by the rising utilization of independent third-party quality controls, as clinical laboratories prioritize unbiased assessment tools over kit-included options to satisfy strict accreditation requirements. This transition is motivated by the necessity to reduce lot-to-lot variability and ensure consistent diagnostic accuracy across various reagent batches, which is essential for ISO 15189 compliance. Laboratories are actively adopting these independent materials to identify systematic errors that might be obscured by the optimized matrix compatibility of manufacturer-supplied controls, a demand reflected in Bio-Rad Laboratories' 'Third-Quarter 2024 Financial Results' from October 2024, where the Clinical Diagnostics segment reported $388.8 million in net sales driven largely by global demand for quality control products.

In parallel, the industry is undergoing a notable shift toward multiplexed and multi-analyte control panels aimed at enhancing workflow efficiency in high-volume testing settings. As diagnostic manufacturers combine multiple targets into single syndromic panels-especially for gastrointestinal and respiratory pathogens-laboratories need consolidated control materials capable of validating all targets at once, thereby cutting down on consumable costs and time associated with single-analyte controls. This consolidation bolsters the scalability of modern diagnostic centers, a trend supported by Revvity's 'Financial Results for the Third Quarter of 2024' in November 2024, which showed the Diagnostics segment generating $383 million in revenue, a 6% increase attributed to the continued adoption of specialized molecular and immunodiagnostic solutions.

Key Market Players

• F. Hoffmann-La Roche Ltd.
• Danaher Corporation
• Bio-Rad Laboratories, Inc.
• Anchor Molecular Inc.
• Thermo Fisher Scientific, Inc.
• Randox Laboratories Ltd.
• Abbott Laboratories Inc.
• Fortress Diagnostics Ltd
• Ortho-Clinical Diagnostics, Inc.
• Sun Diagnostics, LLC

Report Scope

In this report, the Global Molecular Quality Control Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Molecular Quality Control Market, By Product

• Independent Controls
• Instrument-Specific Controls

Molecular Quality Control Market, By Analyte Type

• Single-Analyte Controls
• Multi-Analyte Controls

Molecular Quality Control Market, By Application

• Infectious Disease Diagnostics
• Oncology Testing
• Genetic Testing
• Others

Molecular Quality Control Market, By End-User

• Diagnostic Laboratories
• Hospitals
• IVD Manufacturers & Contract Research Organizations
• Academic & Research Institutes
• Others

Molecular Quality Control Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Molecular Quality Control Market.

Available Customizations:

Global Molecular Quality Control Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Molecular Quality Control Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Independent Controls, Instrument-Specific Controls)
  • 5.2.2. By Analyte Type (Single-Analyte Controls, Multi-Analyte Controls)
  • 5.2.3. By Application (Infectious Disease Diagnostics, Oncology Testing, Genetic Testing, Others)
  • 5.2.4. By End-User (Diagnostic Laboratories, Hospitals, IVD Manufacturers & Contract Research Organizations, Academic & Research Institutes, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America Molecular Quality Control Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Analyte Type
  • 6.2.3. By Application
  • 6.2.4. By End-User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Molecular Quality Control Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Analyte Type
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End-User
  • 6.3.2. Canada Molecular Quality Control Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Analyte Type
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End-User
  • 6.3.3. Mexico Molecular Quality Control Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Analyte Type
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End-User

7. Europe Molecular Quality Control Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Analyte Type
  • 7.2.3. By Application
  • 7.2.4. By End-User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Molecular Quality Control Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Analyte Type
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End-User
  • 7.3.2. France Molecular Quality Control Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Analyte Type
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End-User
  • 7.3.3. United Kingdom Molecular Quality Control Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Analyte Type
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End-User
  • 7.3.4. Italy Molecular Quality Control Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Analyte Type
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End-User
  • 7.3.5. Spain Molecular Quality Control Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Analyte Type
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End-User

8. Asia Pacific Molecular Quality Control Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Analyte Type
  • 8.2.3. By Application
  • 8.2.4. By End-User
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Molecular Quality Control Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Analyte Type
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End-User
  • 8.3.2. India Molecular Quality Control Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Analyte Type
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End-User
  • 8.3.3. Japan Molecular Quality Control Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Analyte Type
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End-User
  • 8.3.4. South Korea Molecular Quality Control Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Analyte Type
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End-User
  • 8.3.5. Australia Molecular Quality Control Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Analyte Type
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End-User

9. Middle East & Africa Molecular Quality Control Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Analyte Type
  • 9.2.3. By Application
  • 9.2.4. By End-User
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Molecular Quality Control Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Analyte Type
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End-User
  • 9.3.2. UAE Molecular Quality Control Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Analyte Type
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End-User
  • 9.3.3. South Africa Molecular Quality Control Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Analyte Type
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End-User

10. South America Molecular Quality Control Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Analyte Type
  • 10.2.3. By Application
  • 10.2.4. By End-User
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Molecular Quality Control Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Analyte Type
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End-User
  • 10.3.2. Colombia Molecular Quality Control Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Analyte Type
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End-User
  • 10.3.3. Argentina Molecular Quality Control Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Analyte Type
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End-User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Molecular Quality Control Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. F. Hoffmann-La Roche Ltd.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Danaher Corporation
• 15.3. Bio-Rad Laboratories, Inc.
• 15.4. Anchor Molecular Inc.
• 15.5. Thermo Fisher Scientific, Inc.
• 15.6. Randox Laboratories Ltd.
• 15.7. Abbott Laboratories Inc.
• 15.8. Fortress Diagnostics Ltd
• 15.9. Ortho-Clinical Diagnostics, Inc.
• 15.10. Sun Diagnostics, LLC

16. Strategic Recommendations

17. About Us & Disclaimer